Rather than lose their shirts with the latest StockTips pick, traders with some foresight chose to grab a piece of Millennium Healthcare, Inc. (MHCC) on Monday. Shares of the medical device and healthcare support and services company had been on an unstoppable decline, down -98%, since their $1.50 high from nearly a year ago until yesterday when MHCC stock jumped 74% after finally finding the bottom last week Friday. With an enormous amount of revenue due to be released for the final three months of 2014, the bottom could have finally been reached with some erect trading sessions to follow from Monday’s.
Want to crush the Markets and make profits of $624, $2,897, even $40,656?
Click HERE To Make Sure You Get All Of Our Penny Stock Alerts!
MHCC Stock Quote / Chart
Millennium has been extremely quiet during 2015, having not issued news since early December which detailed the expansion of its executive management team with the appointment of Paul Antogiovanni as senior vice president of oncology products. The addition of the veteran of the pharmaceutical and biotech industry who began his career as an assistant scientist at Pfizer came just two weeks after Dominic Sartorio, CEO of the Company provided details on its sales and distribution model as it advances a commercial strategy with efficient use of sales resources and a creative marketing approach for its wholly owned subsidiary, Millennium Medical Devices.
Sartorio noted how third quarter total revenue for the three months ending September 30 was $6.4 million, of which $5.9 million was from the sale of OralCDx® and VasoScan™ diagnostic devices. As explosive as the news was, MHCC shares traded over 1 million shares but failed to climb, closing at 0.24 for the day.
For the nine months ended September 30, 2014, Millennium had total revenue of $7,427,290 as compared to revenue of $1,483,107 for the nine months ended September 30, 2013. The $5,944,183, 400.8%, increase over prior period was directly due to the initial distribution and placement of medical devices within a contracted network and the acquisition of call answering service customers. Of the total revenue booked, $5,915,419 stemmed from the distribution and placement of the Company’s medical devices.
The fact that revenues are overflowing in comparison to when MHCC shares traded well above their current PPS is indicative of a strong bullish reason why grabbing a bit and stashing it away could be a smart move. If you’re unsure as to whether or not MHCC shares are worth getting into, consider these factors from their Q3 filings:
In October 2014, the Company authorized and approved 12,000,000 warrants, with an exercise price of $0.25, for its executive officers. These warrants shall be disseminated prior to December 31, 2014.
In October 2014, the Company entered into a short term $250,000 Promissory Note with an individual. The note has a maturity of 30 days and interest on the note is fixed at 175,000 shares of common stock ($1.42 per share).
In October 2014, the Company entered into a short term $450,000 Promissory Note with an individual. The note has a maturity of 60 days and interest on the note is fixed at 300,000 shares of common stock ($1.50 per share).
In October 2014, the Company entered into a short term $40,000 Promissory Note with an individual. The note has a maturity of one year and interest on the note is fixed at 10% per annum.
In October 2014, the Company negotiated and completed a settlement and full satisfaction of certain promissory and demand notes. The settlements included the issuance of 4,600,000 shares of common stock during September 2014 and payments of $450,000 during October 2014 ($0.097 per share).
Looking for the Best Penny Stocks to Buy?
Click HERE To Receive FREE Penny Stock Alerts
About MHCC Stock
Millennium HealthCare Inc., through its wholly owned operating subsidiaries, provides primary care physician practices, physician groups and healthcare facilities of all sizes with cutting edge medical devices focused primarily on preventive care through early detection.
400 Garden City Plaza
Garden City, NY 11530
Email: [email protected]
Issued and Outstanding: 131,548,942
Last 5 Trading Sessions:
MHCC might not have been the biggest gaining or highest traded penny stock Monday, but it sure did hit the radar screens of some veteran traders. With an expectation that news of full year results and the reason for having increased their authorized shares will soon come, MHCC stock deserves some strong attention prior to rising above the 0.10 mark.
We are 100% Anti-Spam and will never rent or sell your information.
Many of our picks go up 100%, 200%, even 10,000%, see for yourself.